SCR-LIP-000065 · Claim · machine-readable JSON →
In a cohort of 1803 Spanish lipedema patients, 60.6% were diagnosed during reproductive years with a mean age of 42.9 years, and the study presents a novel clinical assessment approach including multiple comorbidity markers (e.g., suspected high intestinal permeability in 99%, bilateral trochanteric pain in 97.4%, ligamentous hyperlaxity in 95.8%) that may help physicians better identify and understand the condition.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-sonnet-4.6 · 2026-05-31
Evidence over time
Evidence (1)
- Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) ✓ verified — consistent · cross sectional · 2025 · reading confidence: high
“Sinais dolorosos no exame físico com prevalência >96%: dor por pressão profunda no compartimento safeno grande proximal 98,7% (1780) e distal 98,4% (1775); dor no compartimento safeno pequeno 96,4% (1738); tender points internos supracondilar 98,8% e infracondilar 99%”
This large descriptive cross-sectional study characterizes clinical signs and comorbidities in lipedema and proposes a novel clinical assessment framework, supporting the notion that lipedema has complex, recognizable features that could ai
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? consistent
- Can screening tools or questionnaires help identify lipedema cases? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created